Therapy and Diagnostics based on Organic BioElectonics

Reference number
Coordinator Linköpings universitet - Institutionen för teknik och naturvetenskap
Funding from Vinnova SEK 25 199 605
Project duration February 2011 - February 2016
Status Completed

Purpose and goal

We have met the (revised) aims. We have demonstrated: multiple cell/tissue release technologies, and opened a new field of bioelectronics using ferroelectric polymers; with the ion pump, the first ever use of an organic electronic therapy in an awake animal; with the pe-probes, a tool to identify cancer stem cells with better efficiency than clinical standards. The probes have already been spun-off, and the drug delivery devices will be spun-off soon.

Results and expected effects

With our successful results in all three project areas, and the ongoing commercialization of pe-probes, we believe that we can already offer the medtech industry a range of new theranostic tools. The ion pump has been a ´harder sell´, but we think we are finally poised to commercialize it as well (especially given some recent results). Finally, with the latest materials, the release surfaces are also significantly closer to clinical use.

Approach and implementation

The project was significantly effected by the loss of AstraZeneca and St. Jude. We were forced to focus much more of our time on re-establishing industry partners than on the research and development we originally planned. The revision at halftime, and establishment of a board helped. However, we still suffered from the lack of industrial end-users in the consortium. Perhaps we would be closer to commercialization if we hadn´t lost our original partners.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2010-00507

Page statistics